To further investigate the role of SETD1A in HCC stemness, we first used ATAC-Seq assay to determine its chromatin states in liver CSCs and found its promoter region was more accessible in CD24+CD133+ liver CSCs than in CD24–CD133– non-CSCs (Figure 1E). The gene discussed is SETD1A; the disease is hepatocellular carcinoma.